Low GFI1 expression in white blood cells of CP-CML patients at diagnosis is strongly associated with subsequent blastic transformation

Leukemia

Volumn 27, Issue 6, 2013, Pages 1427-1430

  Kok, C H ^a,b   Watkins, D B ^a,b   Leclercq, T ^a   D'Andrea, R J ^a,b,c   Hughes, T P ^a,b   White, D L ^a,b,d  

^a University of Adelaide   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR INDEPENDENCE 1; IMATINIB; ORGANIC CATION TRANSPORTER 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BLAST CELL CRISIS; BLAST TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE ASSOCIATION; HUMAN; IN VIVO STUDY; LETTER; LEUKOCYTE; LEUKOCYTE DIFFERENTIAL COUNT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

CELL PROLIFERATION; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PROTO-ONCOGENE PROTEINS C-BCL-2; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 84878916342     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.47     Document Type: Letter

References (16)

1. Lidonnici MR, Audia A, Soliera AR, Prisco M, Ferrari-Amorotti G, Waldron T et al. Expression of the transcriptional repressor Gfi-1 is regulated by C/EBPa and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells. Cancer Res 2010; 70: 7949-7959.
2. Soliera AR, Mariani SA, Audia A, Lidonnici MR, Addya S, Ferrari-Amorotti G et al. Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1. Leukemia 2012; 26: 1555-1563.
3. Dvinge H, Bertone P. HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R. Bioinformatics 2009; 25: 3325-3326.
4. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
5. van der Meer LT, Jansen JH, van der Reijden BA. Gfi1 and Gfi1b: key regulators of hematopoiesis. Leukemia 2010; 24: 1834-1843.
6. Huang M, Hu Z, Chang W, Ou D, Zhou J, Zhang Y. The growth factor independence-1 (Gfi1) is overexpressed in chronic myelogenous leukemia. Acta Haematol 2010; 123: 1-5.
7. Marin D, Ibrahim AR, Lucas C, Gerrard G, Wang L, Szydlo RM et al. Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. J Clin Oncol. 2012; 30: 232-238.
8. White DL, Saunders VA, Quinn SR, Manley PW, Hughes TP. Imatinib increases the intracellular concentration of nilotinib, which may explain the observed synergy between these drugs. Blood 2007; 109: 3609-3610. (Pubitemid 46572560)
9. White DL, Dang P, Engler J, Frede A, Zrim S, Osborn M et al. Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronicphase chronic myeloid leukemia treated with imatinib. J Clin Oncol. 2010; 28: 2761-2767.
10. O'Hare T, Eide CA, Deininger MW. Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia. Blood 2007; 110: 2242-2249. (Pubitemid 47523141)
11. Sokal JE, Cox EB, Baccarani M, Tura S, Gomez GA, Robertson JE et al. Prognostic discrimination in 'good-risk' chronic granulocytic leukemia. Blood 1984; 63: 789-799. (Pubitemid 14141296)
12. McWeeney SK, Pemberton LC, Loriaux MM, Vartanian K, Willis SG, Yochum G et al. A gene expression signature of CD34 cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib. Blood 2010; 115: 315-325.
13. Radich JP, Dai H, Mao M, Oehler V, Schelter J, Druker B et al. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci USA 2006; 103: 2794-2799.
14. Horman SR, Velu CS, Chaubey A, Bourdeau T, Zhu J, Paul WE et al. Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood 2009; 113: 5466-5475.
15. Khandanpour C, Kosan C, Gaudreau MC, Duhrsen U, Hebert J, Zeng H et al. Growth factor independence 1 protects hematopoietic stem cells against apoptosis but also prevents the development of a myeloproliferative-like disease. Stem Cells 2011; 29: 376-385.
16. Yucel R, Karsunky H, Klein-Hitpass L, Moroy T. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med 2003; 197: 831-844. (Pubitemid 36437861)